Multicomponent Physical Activity Intervention for the Reduction of Psychosocial Distress in Cancer Patients

Efficacy of an Adapted Multicomponent Physical Activity Intervention to Reduce Psychosocial Distress in Rural Adults Following Cancer Diagnosis

This study adapts and assesses the effect of a multicomponent physical activity intervention in reducing psychosocial distress in cancer patients. This study aims to develop a program to help increase physical activity and reduce stress in cancer survivors who live in rural areas.

Study Overview

• Status: Terminated
• Conditions: Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm; Anxiety Disorder
• Intervention / Treatment: Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Other: Best Practice; Behavioral: Behavioral Intervention; Other: Informational Intervention

Detailed Description

PRIMARY OBJECTIVES:

I. To adapt a multicomponent intervention (HH+AIM) that assesses the perspective of health care provider and cancer survivors about:

Ia. Needs related to psychosocial distress and health behaviors in rural patients with cancer.

Ib. Needs related to implementing interventions within the treatment setting. Ic. Barriers to intervention delivery/participate. Id. Preferred means/methods for referring participants and receiving information related to the intervention.

SECONDARY OBJECTIVES:

I. To assess time spent sitting in prolonged bouts of 20 consecutive minutes or more (minutes/day).

II. To assess daily number of steps (collected using the activPAL over 7 days at week 8, data will be averaging over 7 days to get minutes per day).

III. To assess psychosocial distress measured using the National Comprehensive Cancer Network (NCCN) Distress Thermometer scores.

IV. To assess health-related quality of life measured using the SF-36 short form.

OUTLINE:

PART I: Patients and providers complete a questionnaire and attend an interview over 1 hour.

PART II: Patients are randomized to 1 of 2 groups.

GROUP I: Patients attend face-to-face mind-body sessions focused on stretching, breathing, and relaxation twice a week and receive targeted text messages daily on their smartphone for 8 weeks.

GROUP II: Patients receive usual care.

• Study Type: Interventional
• Enrollment (Actual): 2
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Texas
    • Houston, Texas, United States, 77030
      • M D Anderson Cancer Center

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• PROVIDERS: Work with cancer survivors (e.g., radiation and medical oncologists, oncology nurses, oncology patient navigators, and clinical research coordinators)
• PROVIDERS: Place of engagement falls within a rural county in Texas
• PROVIDERS: Able to read, speak, and write in English
• PROVIDERS: At least 18 years old
• PROVIDERS: Have access to a smartphone, tablet, or computer with internet access and willing to attend virtual sessions
• INTERVIEW SURVIVORS: Men and women >= 18 years of age
• INTERVIEW SURVIVORS: History of cancer
• INTERVIEW SURVIVORS: Currently receiving treatment or have recently completed treatment but are still attending appointments at UTHealth North Campus Tyler (=< 1 year)
• INTERVIEW SURVIVORS: Able to read, speak, and write in English
• INTERVIEW SURVIVORS: Have access to a smartphone, tablet, or computer with internet access and willing to attend virtual sessions
• INTERVENTION SURVIVORS: Men and women >= 18 years of age
• INTERVENTION SURVIVORS: Received a solid tumor cancer diagnosis stage I-III
• INTERVENTION SURVIVORS: Receiving radiation therapy or planning to receive radiation therapy for a solid tumor diagnosis for at least 4 weeks
• INTERVENTION SURVIVORS: Able to engage in moderate intensity physical activity as determined by the Physical Activity Readiness Questionnaire (PAR-Q) or by physicians clearance (letter from physician or nurse practitioner)
• INTERVENTION SURVIVORS: Physician clearance to participate in the study
• INTERVENTION SURVIVORS: Physically inactive (=< 60 minutes of moderate or greater physical activity [PA] per week during the past 6 months)
• INTERVENTION SURVIVORS: Live within MD Anderson's rural catchment area
• INTERVENTION SURVIVORS: Have a home address where information can be mailed and a working telephone
• INTERVENTION SURVIVORS: Have access to a smartphone, tablet, or computer with internet access and willing to attend virtual sessions
• INTERVENTION SURVIVORS: Able to read, speak, and write in English
• INTERVENTION SURVIVORS: Able to receive text messages on their smartphone (via cellular data or wireless internet)

Exclusion Criteria:

• PROVIDERS: Does not work with cancer survivors
• PROVIDERS: Place of work or engagement falls within an urban/metropolitan county in Texas
• PROVIDERS: Does not read, speak, or write in English
• PROVIDERS: Below the age of 18 years
• INTERVIEW SURVIVORS: No history of cancer
• INTERVIEW SURVIVORS: Does not read, speak, or write in English
• INTERVIEW SURVIVORS: Below the age of 18
• INTERVENTION SURVIVORS: No history of cancer
• INTERVENTION SURVIVORS: Have absolute contraindications to unassisted physical activity (e.g., acute myocardial infarction, severe orthopedic or musculoskeletal limitations)
• INTERVENTION SURVIVORS: Currently participating in another intervention to increase physical activity or reduce sedentary behavior
• INTERVENTION SURVIVORS: Self-report meeting physical activity recommendations (>= 60 minutes of moderate or greater PA per week during the past 6 months)
• INTERVENTION SURVIVORS: Physical limitations that might be aggravated by participation in moderate-intensity physical activity as measured using the Physical Activity Readiness Questionnaire (PAR-Q), and any physical limitation that prevents engaging in moderate intensity exercise
• INTERVENTION SURVIVORS: Primary address falls within an urban/metropolitan county in Texas
• INTERVENTION SURVIVORS: Plan to move from the area or discontinue their treatment at UTHealth North Campus Tyler during the 14-week study period
• INTERVETION SURVIVORS: Does not read, speak, or write in English
• INTERVENTION SURVIVORS: Below the age of 18
• INTERVENTION SURVIVORS: Pregnant or planning to become pregnant during the 14 week study period

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Group I (physical activity intervention); Patients attend face-to-face mind-body sessions focused on stretching, breathing, and relaxation twice a week and receive targeted text messages daily on their smartphone for 8 weeks.	Other: Quality-of-Life Assessment; Ancillary studies; Other Names: Quality of Life Assessment; Other: Questionnaire Administration; Ancillary studies; Behavioral: Behavioral Intervention; Attend face-to-face mind-body sessions; Other Names: Behavior Conditioning Therapy; Behavior Modification; Behavior or Life Style Modifications; Behavior Therapy; Behavioral Interventions; Behavioral Modification; Behavioral Therapy; Behavioral Treatment; Behavioral Treatments; Other: Informational Intervention; Receive targeted text messages
Active Comparator: Group II (usual care); Patients receive usual care.	Other: Quality-of-Life Assessment; Ancillary studies; Other Names: Quality of Life Assessment; Other: Questionnaire Administration; Ancillary studies; Other: Best Practice; Receive usual care; Other Names: standard of care; standard therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
To establish a multicomponent intervention that assesses the perspective of health care provider	Through study completion, an average of 1 year
To establish a multicomponent intervention that assesses the perspective of cancer survivors	Through study completion, an average of 1 year

Collaborators and Investigators

• Sponsor: M.D. Anderson Cancer Center
• Collaborators: National Cancer Institute (NCI); Kawut, Steven, MD
• Investigators: Principal Investigator: Scherezade Mama, MD, M.D. Anderson Cancer Center

Publications and helpful links

Helpful Links

• M D Anderson Cancer Center

Study record dates

Study Major Dates

• Study Start (Actual): June 21, 2021
• Primary Completion (Actual): October 7, 2024
• Study Completion (Actual): October 7, 2024

Study Registration Dates

• First Submitted: August 25, 2021
• First Submitted That Met QC Criteria: September 16, 2021
• First Posted (Actual): September 27, 2021

Study Record Updates

• Last Update Posted (Actual): October 23, 2024
• Last Update Submitted That Met QC Criteria: October 21, 2024
• Last Verified: October 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Mental Disorders; Neoplasms; Anxiety Disorders
• Other Study ID Numbers: 2020-1278 (Other Identifier: M D Anderson Cancer Center); NCI-2021-09572 (Registry Identifier: CTRP (Clinical Trial Reporting Program)); K07CA222335 (U.S. NIH Grant/Contract); R01HL142732 (U.S. NIH Grant/Contract)

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No